ENVALITH
大研医器株式会社 logo

DAIKEN MEDICAL CO.,LTD.

7775Standard MarketPrecision Instruments

大研医器株式会社 logo
DAIKEN MEDICAL CO.,LTD.7775
Reference Indicators

Market Cap

137¥100M

P/E (Forecast)

P/B

1.6x

Dividend Yield (Forecast)

4.66%

ROE

12.1%

EV/EBITDA

8.5x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
8,5409,1379,7509,95110,290
Cost of Sales
4,8565,6065,7685,8546,339
Gross Profit
3,6833,5303,9814,0963,951
SG&A Expenses
2,5332,4752,5392,5842,673
Operating Income
1,1501,0541,4421,5121,277
Non-operating Income
531279
Non-operating Expenses
344912
Ordinary Income
1,1521,0531,4501,5101,274
Extraordinary Income
00
Extraordinary Losses
12813228
Pre-tax Income
1,1511,0251,4361,5081,246
Income Taxes
320312447410323
Net Income
8317129881,097922
EBITDA
1,4651,3211,6561,7441,535
Gross Margin
43.1%38.6%40.8%41.2%38.4%
Operating Margin
13.5%11.5%14.8%15.2%12.4%
ROA
7.6%6.5%9.0%9.8%8.1%
ROE
13.2%10.9%14.6%15.2%12.1%